
-
Reagents
- Flow Cytometry Reagents
-
Western Blotting and Molecular Reagents
- Immunoassay Reagents
-
Single-Cell Multiomics Reagents
- BD® OMICS-Guard Sample Preservation Buffer
- BD® AbSeq Assay
- BD® Single-Cell Multiplexing Kit
- BD Rhapsody™ ATAC-Seq Assays
- BD Rhapsody™ Whole Transcriptome Analysis (WTA) Amplification Kit
- BD Rhapsody™ TCR/BCR Next Multiomic Assays
- BD Rhapsody™ Targeted mRNA Kits
- BD Rhapsody™ Accessory Kits
- BD® OMICS-One Protein Panels
-
Functional Assays
-
Microscopy and Imaging Reagents
-
Cell Preparation and Separation Reagents
-
- BD® OMICS-Guard Sample Preservation Buffer
- BD® AbSeq Assay
- BD® Single-Cell Multiplexing Kit
- BD Rhapsody™ ATAC-Seq Assays
- BD Rhapsody™ Whole Transcriptome Analysis (WTA) Amplification Kit
- BD Rhapsody™ TCR/BCR Next Multiomic Assays
- BD Rhapsody™ Targeted mRNA Kits
- BD Rhapsody™ Accessory Kits
- BD® OMICS-One Protein Panels
- Switzerland (English)
-
Change country/language
Old Browser
This page has been recently translated and is available in French now.
Looks like you're visiting us from United States.
Would you like to stay on the current country site or be switched to your country?
BD Horizon™ Brilliant Stain Buffer


Regulatory Status Legend
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Product Details
Description
The BD Horizon™ Brilliant Stain Buffer is a buffer for the immunofluorescent staining of cells. Brilliant Stain Buffer is a solution that is added to mixtures of certain fluorescent reagents before staining cells. It was designed to complement multicolor flow cytometry experiments that utilize staining reagents conjugated with BD Horizon Brilliant fluorescent polymer dyes. Fluorescent dye interactions may cause staining artifacts which may affect data interpretation. For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime BD Horizon Brilliant dyes are used. The BD Horizon Brilliant Stain Buffer is compatible with the use of other fluorescent staining reagents conjugated with traditional fluorochromes, such as fluorescein, phycoerythrin or Alexa Fluor® dyes.
Preparation And Storage
• Store undiluted at 2–8 °C.• Do not freeze the reagent or expose it to direct light during storage or incubation with cells. Keep the reagent vial dry.• Reagent in opened or unopened bottles is stable until the expiration date shown on the bottle label when stored as directed.
Recommended Assay Procedures
1. Add 50 µL of undiluted BD Horizon™ Brilliant Stain Buffer to each 12 × 75-mm tube.
2. Add the appropriate volume of each fluorochrome-conjugated antibody. NOTE See the antibody reagent IFU for antibody volumes.
3. Vortex to mix well, especially after adding a BD Horizon Brilliant™ reagent.
4. Add 100 µL of the specimen and continue with the staining procedure per the antibody reagent IFU. See the antibody reagent IFU for the staining procedure and storage conditions of stained cells prior to acquisition. If you are staining cells using more than one BD Horizon Brilliant™ Violet reagent in the presence of BD Horizon™ Brilliant Stain Buffer, we recommend acquiring the sample within 6 hours of fixation.
In cases that BD Horizon™ Brilliant Stain Buffer does not adequately resolve DDI, we recommend that you:
- Understand the antigen density of the markers being studied. If DDI is expected, use BD Horizon Brilliant™ Violet reagents for markers expressed at lower levels, if possible.
- Understand the co-expression of markers on the cell types being studied. If dyes exhibiting DDI are used in a panel but the markers are expressed on different cell types and the analysis channels are different for the different cell types, then DDI is not of concern.
- Run trial panels to ensure that when DDI is present, the use of BD Horizon™ Brilliant Stain Buffer minimizes the DDI to such an extent that accurate qualitative decisions can be made. Once the panel has been defined it should then be tested in the presence of bilirubin and hemoglobin to ensure these two potential interferents do not substantively impact the performance of the panel.
Development References (2)
-
Centers for Disease Control and Prevention. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. Available: https://www.cdc.gov/infectioncontrol/guidelines/isolation/index.html March 12, 2019. View Reference
-
Clinical and Laboratory Standards Institute. Protection of Laboratory Workers from Occupationally Acquired Infections. In: CLSI. CLSI, ed. CLSI document M29-A4. Wayne, PA: Clinical and Laboratory Standards Institute; 2014:1-133. View Reference
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.
Documents are subject to revision without notice. Please verify you have the correct revision of the document, and always refer back to BD's eIFU website for the latest and most up to date information.